Figure 1.
Comparison of percentage of resistance to individual ARVs between HIV-1 RNA versus HIV-1 DNA genotypes. Proportion of resistance to individual ARVs identified from HIV-1 DNA genotyping is compared with previous HIV-1 RNA genotype (a) or HIV-1 RNA obtained at the same time (b). ZDV, zidovudine; ddI, didanosine; 3TC, lamivudine; d4T, stavudine; TDF, tenofovir disoproxil fumarate; ABC, abacavir; EFV, efavirenz; NVP, nevirapine; ETV, etravirine; RPV, rilpivirine; IDV, indinavir; SQV/r, saquinavir/ritonavir; NFV, nelfinavir; FPV, fosfamprenavir; ATV/r, atazanavir/ritonavir; LPV/r, lopinavir/ritonavir; DRV/r, darunavir/ritonavir.